Breaking News
September 25, 2018 - Gene therapy approach could help treat mitochondrial diseases
September 25, 2018 - Few Yogurt Products Qualify As Low-Sugar
September 25, 2018 - Eye disease can cause blindness, and it’s on the rise
September 25, 2018 - Pawnshop density linked to gun-related suicides, Stanford study finds
September 25, 2018 - Pioneering procedure for common prostate condition offered by The London Clinic
September 25, 2018 - Number of people with respiratory diseases likely to increase if UK air pollution remains unchecked
September 25, 2018 - FARXIGA receives positive results in Phase III DECLARE-TIMI 58 cardiovascular outcomes trial
September 25, 2018 - New program to reduce harmful stress effectively improves mood in cancer patients
September 24, 2018 - Florence’s Lingering Threat: Mold – Drugs.com MedNews
September 24, 2018 - For professional baseball players, faster hand-eye coordination linked to batting performance
September 24, 2018 - Bill for later school start times is defeated, but Stanford sleep specialist isn’t
September 24, 2018 - For Heart Failure Patients, Mitral Valve Procedure Improved Outcomes
September 24, 2018 - Successful recovery from addiction means more than achieving abstinence
September 24, 2018 - New nanoplatform technology may reverse drug-resistance in renal cell carcinoma
September 24, 2018 - October 1918 marks the centenary of Spanish Flu that claimed more lives than World War I
September 24, 2018 - LGBT community reports more number of poor mental health days than general population
September 24, 2018 - New research suggests power of zebrafish as tool for cancer drug discovery
September 24, 2018 - New study finds height as possible risk factor for developing varicose veins
September 24, 2018 - Researchers compare weight loss results of online and in-person diabetes prevention program
September 24, 2018 - New HER2 PET Study Uses Affibody’s ABY-025 Tracer to Individualize Breast Cancer Treatment
September 24, 2018 - Drug combination offers more effective care for patients suffering miscarriage
September 24, 2018 - Tallness linked to varicose veins, Stanford study says
September 24, 2018 - For Heart Failure Patients, Mitral Valve Procedure Improved Outcomes
September 24, 2018 - Ecstasy drug makes octopuses more social
September 24, 2018 - Immediate compression therapy could cut risk of complications after deep-vein thrombosis
September 24, 2018 - Transcatheter mitral valve repair reduces mortality for patients with mitral regurgitation
September 24, 2018 - First intracranial aneurysm patients treated with BRAVO Flow Diverter after CE mark approval
September 24, 2018 - ‘Physicians of the mouth’? Dentists absorb the medical billing drill
September 24, 2018 - People more likely to believe those with confident tone of voice than with accent
September 24, 2018 - Harmony Biosciences Presents 5-Year Data On Pitolisant At International Narcolepsy Symposium
September 24, 2018 - Blood test may identify gestational diabetes risk in first trimester
September 24, 2018 - Height may be risk factor for varicose veins | News Center
September 24, 2018 - King’s commemorates opening of new NMR facility with one-day symposium
September 24, 2018 - Eisai receives approval for partial label change of DC Bead device for transcatheter arterial embolization
September 24, 2018 - High-resolution genomic map gives scientists unprecedented view of brain development
September 24, 2018 - Researchers find impact of neurobehavioral symptoms on employment in adults with TBI
September 24, 2018 - Alexion announces positive results from Phase 3 PREVENT study of Soliris in patients with NMOSD
September 24, 2018 - First evaluation of benefits, harms of Alzheimer’s screening for family members of older adults
September 24, 2018 - Ancora Heart announces positive data of study evaluating AccuCinch Ventricular Repair System
September 24, 2018 - Children of mothers using cannabis may start using it at an earlier age, finds study
September 24, 2018 - Gilead Sciences plans to launch authorized generic versions of Epclusa and Harvoni in the US
September 24, 2018 - Most patients who underwent transcatheter valve replacement experience prosthesis-patient mismatch
September 24, 2018 - Lumos acquires license for LUM-201 drug that promotes secretion of growth hormone
September 24, 2018 - New study provides basis for Air Canada to change its facial hair policy for aircrew
September 24, 2018 - Infant walkers lead to thousands of emergency visits for babies
September 24, 2018 - Genes predicting person’s height may provide clues about causes of varicose veins
September 24, 2018 - EPA Plan Will Maintain Carbon Emissions From Power Plants
September 24, 2018 - Characterizing pig hippocampus could improve translational neuroscience
September 24, 2018 - Element3 Health reports social and mental engagement play key role in overall health
September 24, 2018 - Paralympic medalists support Fight for Sight’s unique virtual event
September 24, 2018 - ADCETRIS drug receives approval in Japan as frontline treatment option for Hodgkin lymphoma
September 24, 2018 - Public awareness of urological conditions found to be alarmingly low across Europe
September 24, 2018 - Fitter Folks Suffer Milder Strokes: Study
September 24, 2018 - Novel botulinum toxin compound relieves chronic pain
September 24, 2018 - CHMP recommends approval of Gilenya for treatment of multiple sclerosis in children, adolescents
September 24, 2018 - National Friendly’s private medical insurance is a hit with women living in the South East
September 24, 2018 - Academics receive prestigious awards for achievements in blood pressure research
September 24, 2018 - Obese pregnant women can restrict weight gain safely with proper nutrition guidance
September 24, 2018 - CHMP adopts positive opinion of Takeda’s ALUNBRIG for treatment of ALK+ non-small cell lung cancer
September 24, 2018 - China NMPA approves LENVIMA for treatment of unresectable hepatocellular carcinoma
September 24, 2018 - A new approach for finding Alzheimer’s treatments
September 24, 2018 - USC research uncovers previously unknown genetic risk factor for dementia
September 24, 2018 - Study examining mental health among students finds significant disparities in treatment across race
September 24, 2018 - Breakthrough discovery paves way for future test to identify drowsy drivers
September 24, 2018 - Transcatheter mitral-valve repair in patients with heart failure
September 24, 2018 - Study opens new avenues for treatment of Laing distal myopathy
September 24, 2018 - Stroke Facts | cdc.gov
September 24, 2018 - Sarcolipin tricks muscle cells into using more energy, burning fat
September 24, 2018 - Enrollment in opioid controlled substance agreement reduces primary care visits
September 24, 2018 - UTA researchers patent new smart seat cushion technology that helps prevent painful ulcers
September 24, 2018 - Second HPV-Related Primary Cancers Common in Survivors
September 24, 2018 - How a virus destabilizes the genome
September 24, 2018 - Old letters provide insight into Spanish flu pandemic horror
September 23, 2018 - Smart textile-based soft robotic exosuit helps wearers save energy and traverse difficult terrain
September 23, 2018 - New research hub to drive radical change in development and manufacturing of vaccines
September 23, 2018 - AHA: For Hispanics, Neighborhood May Be Key Factor in Heart Disease Risk
September 23, 2018 - Excessive airway nerves tied to more severe asthma symptoms, study finds
September 23, 2018 - Study highlights need to remain vigilant in maintaining key infection control processes
September 23, 2018 - Novel therapeutic strategy for blood vessel related disorders, such as cancer and retinopathy
September 23, 2018 - New naturally occurring antibiotic found effective against Mycobacterium tuberculosis
May just Germs within the Intestine Give Upward thrust to Power Fatigue Syndrome?

May just Germs within the Intestine Give Upward thrust to Power Fatigue Syndrome?

image_pdfDownload PDFimage_print

HealthDay news image

THURSDAY, April 27, 2017 (HealthDay Information) — Scientists have discovered variations within the intestine micro organism of other people with continual fatigue syndrome as opposed to their wholesome friends.

The discovering is likely one of the first to hyperlink abnormalities within the make-up of intestine micro organism — the “microbiome” — and protracted fatigue, a mysterious and debilitating illness.

Whether or not those variations are simply an indication of continual fatigue syndrome or an underlying motive is not transparent, stated find out about lead writer Dr. W. Ian Lipkin.

However they might be tied to illness severity, stated Lipkin. He’s director of the Heart for An infection and Immunity at Columbia College Mailman College of Public Well being.

Power fatigue syndrome impacts about 1 million American citizens — ladies extra steadily than males, in line with the U.S. Facilities for Illness Regulate and Prevention.

Other people with the syndrome generally whinge of maximum fatigue after exertion, muscle and joint ache, considering problem and sleep issues. However most effective about 20 p.c of people that have the syndrome in reality realize it, as a result of it is tricky to diagnose, the CDC notes.

Scientists have begun to seem to the microbiome for solutions to a number of clinical mysteries.

Your microbiome is the neighborhood of micro organism residing on and to your frame. “On this case, we’re describing the micro organism to your intestines,” stated Lipkin.

“Those micro organism affect how we really feel, how our immune methods reply to our surroundings and our resistance to illness,” he added.

To discover a possible affiliation between continual fatigue syndrome and an imbalance within the intestine setting, researchers recruited 50 sufferers with continual fatigue syndrome and 50 wholesome friends from 4 U.S. towns. Maximum had been ladies, moderate age 51.

Fecal samples from all individuals had been genetically damaged down to spot the categories and amount of micro organism provide. Blood samples had been additionally analyzed.

What the investigation discovered is that individuals with continual fatigue syndrome “have other micro organism of their intestines than more fit other people,” Lipkin stated.

Particularly, the analysis workforce noticed that continual fatigue sufferers — however no longer the wholesome individuals — had top amounts of a number of intestinal micro organism species.

Additionally, amongst other people with continual fatigue syndrome, investigators discovered that bacterial composition perceived to shift relying on illness severity.

Each associations held up without reference to whether or not or no longer an individual with continual fatigue syndrome additionally had irritable bowel syndrome. The 2 steadily move hand-in-hand.

“This find out about is an early however necessary step towards figuring out the composition of a wholesome microbiome,” stated Lipkin. In the end, the findings might assist diagnoses and level to new therapies concentrated on subtypes of continual fatigue, he and his colleagues recommended.

“Because the paintings continues,” Lipkin added, “we look forward to that physicians will be capable to make explicit suggestions that affect the composition of our microbiomes, and cut back some signs of [chronic fatigue syndrome].”

These days, there aren’t any licensed therapies for continual fatigue syndrome in the USA.

Alternatively, one physician cautioned that a lot more analysis is wanted first.

There’s not likely to be a unmarried clarification or “silver bullet” for the syndrome, stated Dr. Jim Pagel. He’s an affiliate scientific professor with the College of Colorado Scientific College Gadget.

Pagel famous that microbiome abnormalities would possibly replicate only one “secondary” issue associated with, however no longer inflicting, continual fatigue syndrome. A lot of elements might be concerned.

The ground-line: “We’ve just a very restricted working out as to what makes up an acceptable nutrition and the associations of gastrointestinal vegetation with sickness,” stated Pagel. “There’s way more we do not know than what we do know.”

The findings had been printed on-line April 26 within the magazine Microbiome.

SOURCES: W. Ian Lipkin, M.D., professor, epidemiology, and director, Heart for An infection and Immunity, Columbia College Mailman College of Public Well being, New York Town; Jim Pagel, M.D., affiliate scientific professor, College of Colorado Scientific College Gadget, and director, Sleep Issues Heart of Southern Colorado, Pueblo, Colo.; April 26, 2017, Microbiome, on-line

Information tales are written and equipped through HealthDay and don’t replicate federal coverage, the perspectives of MedlinePlus, the Nationwide Library of Drugs, the Nationwide Institutes of Well being, or the U.S. Division of Well being and Human Products and services.

Tagged with:

About author

Related Articles